These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6826812)

  • 1. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.
    Kaplan RP; Russell DH; Lowe NJ
    J Am Acad Dermatol; 1983 Jan; 8(1):95-102. PubMed ID: 6826812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased urinary polyamines in patients with psoriasis treated with etretinate.
    Grekin RC; Ellis CN; Goldstein NG; Swanson NA; Anderson TF; Duell EA; Voorhees JJ
    J Invest Dermatol; 1983 Mar; 80(3):181-4. PubMed ID: 6827127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of increased polyamine levels in psoriatic lesions by retinoid and PUVA treatments.
    Lauharanta J; Kousa M; Kapyaho K; Linnamaa K; Mustakallio K
    Br J Dermatol; 1981 Sep; 105(3):267-72. PubMed ID: 7272207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase.
    Lowe NJ; Kaplan R; Breeding J
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):697-8. PubMed ID: 7068977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratin polypeptide profile in psoriatic epidermis normalized by treatment with etretinate (aromatic retinoid Ro 10-9359).
    Staquet MJ; Faure MR; Reano A; Viac J; Thivolet J
    Arch Dermatol Res; 1983; 275(2):124-9. PubMed ID: 6191725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jul; 26(1):9-43. PubMed ID: 6224672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis.
    Ellis CN; Gold RC; Grekin RC; Anderson TF; Swanson NA; Voorhees JJ
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):699-704. PubMed ID: 7068978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP; Matt LH; Lowe NJ
    Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359).
    Lassus A
    Br J Dermatol; 1980 Feb; 102(2):195-202. PubMed ID: 6992833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of epidermal polyamines to orally administered aromatic retinoid RO 10-9359.
    El Baze P; Milano G; Verrando P; Renee N; Ortonne JP
    Arch Dermatol Res; 1984; 276(2):99-101. PubMed ID: 6721578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic retinoid therapy for psoriasis.
    Lowe NJ; Lazarus V; Matt L
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.